ResMed (RMD) Acquired Laboratoires Narval
More News related to RMD
- Notable Analyst Rating Changes 11/06: GE, CBS, HD/LOW, M Upgrade; ESLR, RMD, SUN Downgrade
- Morgan Stanley Downgrades ResMed (RMD) to Equalweight
- Jefferies & Co Downgrades ResMed (RMD) to Hold
- ResMed (RMD) Tops Q3 Views
- ResMed Inc. Announces Record Financial Results for the Quarter Ended September 30, 2009
ResMed Inc. (NYSE: RMD) acquired Laboratoires Narval. Based in France, Laboratoires Narval manufactures and distributes the Narval O.R.M.(TM), an innovative mandibular repositioning device (MRD) that offers a solution to patients for snoring and obstructive sleep apnea (OSA), especially for those with mild OSA.
With this acquisition, ResMed adds another therapy to supplement its existing positive airway pressure-based solutions, providing a broader offering for this patient group. ResMed plans to commercialize this device in selected European markets.
Related Categories
Mergers and AcquisitionsStocks Mentioned
+0.73Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
